These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 31845824)

  • 1. Different prognostic significance of examined lymph node count for patients with non-small-cell lung cancer ≤1 cm or >1-2 cm: a population-based study.
    Liang Z; Wang X; Yang H; Fu H; Li M; Feng Z; Peng Z; Wang H
    Future Oncol; 2020 Jan; 16(3):4497-4509. PubMed ID: 31845824
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic Significance of Lymph Node Count Removed at Sublobar Resection in Pathologic Stage IA Non-Small-cell Lung Cancer: A Population-Based Analysis.
    He Z; Li Z; Xu S; Wu W; Zhu Q; Wang J; Wen W; Chen L
    Clin Lung Cancer; 2021 Jul; 22(4):e563-e573. PubMed ID: 33214078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Examined Lymph Node Count on Precise Staging and Long-Term Survival of Resected Non-Small-Cell Lung Cancer: A Population Study of the US SEER Database and a Chinese Multi-Institutional Registry.
    Liang W; He J; Shen Y; Shen J; He Q; Zhang J; Jiang G; Wang Q; Liu L; Gao S; Liu D; Wang Z; Zhu Z; Ng CS; Liu CC; Petersen RH; Rocco G; D'Amico T; Brunelli A; Chen H; Zhi X; Liu B; Yang Y; Chen W; Zhou Q; He J
    J Clin Oncol; 2017 Apr; 35(11):1162-1170. PubMed ID: 28029318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of metastatic lymph nodes ratio in overall survival for patients with resected nonsmall cell lung cancer: a retrospective cohort study.
    Lin X; Yao J; Huang B; Chen T; Xie L; Huang R
    Eur J Cancer Prev; 2024 Jul; 33(4):376-385. PubMed ID: 38842873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative Lymph Node Count Predicts Survival of Resected Non-small Cell Lung Cancer.
    Zhou X; Wu C; Cheng Q
    Lung; 2020 Oct; 198(5):839-846. PubMed ID: 32683563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival and Resected Lymph Node Number During Sublobar Resection for N0 Non-Small Cell Lung Cancer 2 cm or Less.
    Ding H; Wang H; Xu L; Song N; Jiang G
    Ann Thorac Surg; 2019 Jun; 107(6):1647-1655. PubMed ID: 30682353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical choice for patients with stage I non-small-cell lung cancer ≤2 cm: an analysis from surveillance, epidemiology, and end results database.
    Wu L; Zhao W; Chen T; Yang Y
    J Cardiothorac Surg; 2021 Jul; 16(1):191. PubMed ID: 34233699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Choice of postoperative radiation for stage IIIA pathologic N2 non-small cell lung cancer: impact of metastatic lymph node number.
    Wang S; Ma Z; Yang X; Wang Y; Xu Y; Xia W; Chen R; Qiu M; Jiang F; Yin R; Xu L; Xu K
    Radiat Oncol; 2017 Dec; 12(1):207. PubMed ID: 29284511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Choice of Surgical Procedure for Patients With Non-Small-Cell Lung Cancer ≤ 1 cm or > 1 to 2 cm Among Lobectomy, Segmentectomy, and Wedge Resection: A Population-Based Study.
    Dai C; Shen J; Ren Y; Zhong S; Zheng H; He J; Xie D; Fei K; Liang W; Jiang G; Yang P; Petersen RH; Ng CS; Liu CC; Rocco G; Brunelli A; Shen Y; Chen C; He J
    J Clin Oncol; 2016 Sep; 34(26):3175-82. PubMed ID: 27382092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Including positive lymph node count in the AJCC N staging may be a better predictor of the prognosis of NSCLC patients, especially stage III patients: a large population-based study.
    Fan Y; Du Y; Sun W; Wang H
    Int J Clin Oncol; 2019 Nov; 24(11):1359-1366. PubMed ID: 31183778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment and Validation of a Nomogram Based on Negative Lymph Nodes to Predict Survival in Postoperative Patients with non-Small Cell Lung Cancer.
    Huang X; Hu P; Yan F; Zhang J
    Technol Cancer Res Treat; 2022; 21():15330338221074506. PubMed ID: 35060800
    [No Abstract]   [Full Text] [Related]  

  • 12. Time trend of mediastinal lymph node dissection in stage IA non-small cell lung cancer patient who undergo lobectomy: a retrospective study of surveillance, epidemiology, and end results (SEER) database.
    Pan L; Mo R; Zhu L; Yu W; Lv W; Hu J
    J Cardiothorac Surg; 2020 Aug; 15(1):207. PubMed ID: 32738925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinicopathological study of resected non-small cell lung cancers 2 cm or less in diameter: a prognostic assessment.
    Shi CL; Zhang XY; Han BH; He WZ; Shen J; Chu TQ
    Med Oncol; 2011 Dec; 28(4):1441-6. PubMed ID: 20661664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mediastinal lymph node examination and survival in resected early-stage non-small-cell lung cancer in the surveillance, epidemiology, and end results database.
    Osarogiagbon RU; Yu X
    J Thorac Oncol; 2012 Dec; 7(12):1798-1806. PubMed ID: 23154551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do tumours located in the left lower lobe have worse outcomes in lymph node-positive non-small cell lung cancer than tumours in other lobes?
    Kudo Y; Saji H; Shimada Y; Nomura M; Usuda J; Kajiwara N; Ohira T; Ikeda N
    Eur J Cardiothorac Surg; 2012 Sep; 42(3):414-9. PubMed ID: 22398463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Segmentectomy versus lobectomy in early non-small cell lung cancer of 2 cm or less in size: A population-based study.
    Moon MH; Moon YK; Moon SW
    Respirology; 2018 Jul; 23(7):695-703. PubMed ID: 29465766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A hypothesized TNM staging system based on the number and location of positive lymph nodes may better reflect the prognosis for patients with NSCLC.
    Shang X; Liu J; Li Z; Lin J; Wang H
    BMC Cancer; 2019 Jun; 19(1):591. PubMed ID: 31208403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the number of lymph nodes examined on the survival of patients with stage I non-small cell lung cancer who undergo sublobar resection.
    Yendamuri S; Dhillon SS; Groman A; Dy G; Dexter E; Picone A; Nwogu C; Demmy T; Hennon M
    J Thorac Cardiovasc Surg; 2018 Jul; 156(1):394-402. PubMed ID: 29709364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of clinical T4 stage superior sulcus non-small cell lung cancer: a propensity-matched analysis of the surveillance, epidemiology, and end results database.
    Wen J; Liu D; Chen D; Chen J; Xu X; Chen C; Zhang F; Duan S; Zhu R; Fan M; Chen Y
    Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30647107
    [No Abstract]   [Full Text] [Related]  

  • 20. Survival analysis of 220 patients with completely resected stage-II non-small cell lung cancer.
    Dai Y; Su XD; Long H; Lin P; Fu JH; Zhang LJ; Wang X; Wen ZS; Zhu ZH; Zhang X; Rong TH
    Chin J Cancer; 2010 May; 29(5):538-44. PubMed ID: 20426905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.